Eton Pharmaceuticals, Inc. (ETON)
NASDAQHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-11-04
$47.15-7.04%
Close 2026-11-05 · 1-day change
NASDAQHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-11-04
QuarterlyIQ Insights · ETON
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenues | 105.6 | 80.0 | 39.0 | 31.6 | 21.3 | 21.8 |
| Cost of Revenues | 44.5 | 37.2 | 15.6 | 10.6 | 6.9 | 2.8 |
| Gross Profit | 61.1 | 42.7 | 23.4 | 21.1 | 14.3 | 19.0 |
| Operating Expenses & Income | ||||||
| R&D Expenses | 5.8 | 7.8 | 3.3 | 3.3 | 4.0 | 6.2 |
| Operating Income | 16.3 | (0.8) | (2.6) | (1.2) | (8.3) | (1.5) |
| Earnings from Continuing Operations | ||||||
| Interest Expense | — | — | — | 1.1 | 1.0 | 1.0 |
| Other Non-Operating Income / Expenses | — | (3.7) | (1.2) | 0.5 | (0.8) | (1.0) |
| EBT, Incl. Unusual Items | 12.8 | (4.6) | (3.8) | (0.7) | (9.0) | (2.0) |
| Income Tax Expense | 0.1 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 |
| Net Income | ||||||
| Net Income | 12.7 | (4.6) | (3.8) | (0.9) | (9.0) | (2.0) |
| Per Share | ||||||
| Basic EPS | 0.46 | (0.17) | (0.15) | (0.04) | (0.36) | (0.08) |
| Diluted EPS | 0.39 | — | — | — | — | — |
| Revenue per Share | 3.22 | — | — | — | — | — |
| Basic Weighted Avg Shares | 27.6 | 26.9 | 25.9 | 25.6 | 25.1 | 25.2 |
| Diluted Weighted Avg Shares | 32.8 | — | — | — | — | — |
| Supplemental | ||||||
| EBITDA | — | 3.2 | (1.5) | (0.3) | (6.5) | (1.0) |
| EBIT | 16.3 | (0.8) | (2.6) | (1.2) | (8.3) | (1.5) |
| Effective Tax Rate | 0.5% | — | — | -35.8% | 0.0% | 0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.